CPA CPA - Vicarious Surgical CFO Treasurer

RBOT Stock  USD 5.40  0.11  2.00%   

Insider

CPA CPA is CFO Treasurer of Vicarious Surgical
Age 53
Address 78 Fourth Avenue, Waltham, MA, United States, 02451
Phone617 868 1700
Webhttps://www.vicarioussurgical.com

Vicarious Surgical Management Efficiency

The company has return on total asset (ROA) of (0.5773) % which means that it has lost $0.5773 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2563) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.98 in 2025. Return On Capital Employed is likely to drop to -1.16 in 2025. At this time, Vicarious Surgical's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 25.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 5.7 M in 2025.
Vicarious Surgical currently holds 13.79 M in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. Vicarious Surgical has a current ratio of 11.03, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Vicarious Surgical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Claudia DraytonQuantumSi
56
Raja Balindie Semiconductor
N/A
Thomas YorkeyProcept Biorobotics Corp
62
Derrick SungPulmonx Corp
51
Steven Machugaindie Semiconductor
59
Cenk SumenMaxCyte
50
Ehab EsmailOrthofix Medical
53
Minni VittalProcept Biorobotics Corp
N/A
William ScheesseleHumacyte
53
Mark QuickOrthofix Medical
N/A
Scott Keeindie Semiconductor
48
Douglas DoerflerMaxCyte
69
Michael HarburnRigetti Computing
54
BA ChemistryOrthofix Medical
63
Geoffrey RosePulmonx Corp
51
John McKunePulmonx Corp
49
Greg PetersRigetti Computing
64
Jonathan RothbergQuantumSi
61
Lou DeSorboRigetti Computing
N/A
Todd RearickQuantumSi
N/A
Sean MenarguezMaxCyte
N/A
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Vicarious Surgical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 153 people. Vicarious Surgical (RBOT) is traded on New York Stock Exchange in USA. It is located in 78 Fourth Avenue, Waltham, MA, United States, 02451 and employs 121 people. Vicarious Surgical is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Vicarious Surgical Leadership Team

Elected by the shareholders, the Vicarious Surgical's board of directors comprises two types of representatives: Vicarious Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vicarious. The board's role is to monitor Vicarious Surgical's management team and ensure that shareholders' interests are well served. Vicarious Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vicarious Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
CPA CPA, CFO Treasurer
June Esq, Gen Officer
Terry Lundgren, Independent Director
Sammy Khalifa, CTO Cofounder
John Mazzola, VP Operations
Sarah CPA, Chief Officer
Stephen From, CEO Director
Michael Kives, Independent Director
David Ho, Independent Director
William CPA, CFO Treasurer
Randolph Clark, President
Donald Tang, President Director
Emma Plouffe, Senior People
Kaitlyn Brosco, Director Relations
Erin Checka, Head Secretary
David Chu, Chief Executive Officer, Director
Fred Langhammer, Independent Director
MD FACS, Cofounder Officer
Adam Sachs, President CoFounder
Robert Kirby, Chief Financial Officer

Vicarious Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vicarious Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vicarious Stock Analysis

When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.